Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$671K Buy
7,922
+476
+6% +$38.2K 0.1% 204
2026
Q1
$623K Buy
7,446
+3,496
+89% +$263K 0.1% 201
2025
Q4
$265K Sell
3,950
-110
-3% -$7.11K 0.04% 339
2025
Q3
$275K Buy
4,060
+770
+23% +$55.8K 0.04% 349
2025
Q2
$245K Buy
+3,290
New +$219K 0.03% 362
2022
Q2
Sell
-3,616
Closed -$208K 308
2022
Q1
$208K Sell
3,616
-930
-20% -$47.5K 0.04% 314
2021
Q4
$215K Sell
4,546
-474
-9% -$21.6K 0.04% 318
2021
Q3
$212K Buy
+5,020
New +$217K 0.05% 312

Other funds holding CTVA

Chicago Trust's CTVA Position: Q2 2026 in Review

Chicago Trust increased its Corteva (CTVA) stake by 6.4% in Q2 2026, buying an estimated $38.2K and bringing the position to 7,922 shares worth $671K. The position accounts for 0.1% of the portfolio, ranked #204.

Chicago Trust first reported a position in CTVA in Q3 2021 and has held it in 8 quarters since. 302 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Chicago Trust held 7,922 shares of Corteva worth $671K as of Q2 2026.
  • Chicago Trust bought 476 Corteva shares in Q2 2026, an estimated $38.2K.
  • Corteva made up 0.1% of Chicago Trust's portfolio in Q2 2026, its #204 holding.
  • Chicago Trust first reported a position in Corteva in Q3 2021 and has held it in 8 quarters since.
  • 302 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.